Skip to main content

Table 2 OR adjusted for Age and Study Population, stratified by Height

From: Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer

SNP rs nr

Genotype

p-value for interaction

All individuals

Height <162.0 cm

Height 162.0-166.0 cm

Height >166.0 cm

   

case/contr: 2869/4480

case/control: 776/1366

case/control: 967/1407

case/control: 1023/1502

   

OR 95%CI

p-trend

OR 95%CI

p-trend

OR 95%CI

p-trend

OR 95%CI

p-trend

FGFR2 2981582

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.23 (1.10-1.37)

 

1.35 (1.10-1.66)

 

1.33 (1.10-1.61)

 

1.07 (0.89-1.28)

 
 

aa

 

1.48 (1.29-1.69)

 

1.57 (1.21-2.02)

 

1.56 (1.22-1.99)

 

1.32 (1.04-1.67)

 
 

Per Allele

0,41

1.22 (1.14-1.30)

1.34E-08

1.26 (1.11-1.43)

2.86E-04

1.26 (1.12-1.42)

1.65E-04

1.14 (1.01-1.28)

0.03

TNR09 3803662

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.14 (1.03-1.26)

 

1.09 (0.90-1.32)

 

1.23 (1.03-1.47)

 

1.15 (0.97-1.36)

 
 

aa

 

1.39 (1.17-1.67)

 

1.37 (1.00-1.87)

 

1.37 (1.00-1.89)

 

1.42 (1.03-1.95)

 
 

Per Allele

0,91

1.16 (1.08-1.25)

5.34E-05

1.14 (1.00-1.31)

0.06

1.20 (1.05-1.37)

6.78E-03

1.17 (1.03-1.33)

0.02

MAP3K1 889312

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.21 (1.09-1.34)

 

1.29 (1.06-1.55)

 

1.14 (0.95-1.36)

 

1.18 (1.00-1.40)

 
 

aa

 

1.29 (1.09-1.54)

 

1.31 (0.95-1.81)

 

1.05 (0.76-1.45)

 

1.53 (1.14-2.06)

 
 

Per Allele

0,45

1.17 (1.08-1.26)

4.26E-05

1.20 (1.04-1.37)

9.92E-03

1.07 (0.94-1.22)

0.29

1.22 (1.07-1.38)

2.20E-03

8q24 13281615

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.12 (1.00-1.24)

 

1.21 (0.98-1.48)

 

1.07 (0.89-1.29)

 

1.12 (0.93-1.34)

 
 

aa

 

1.15 (1.00-1.32)

 

1.24 (0.96-1.60)

 

1.17 (0.92-1.49)

 

1.09 (0.87-1.38)

 
 

Per Allele

0,90

1.08 (1.01-1.15)

0.03

1.12 (0.99-1.27)

0.07

1.08 (0.96-1.22)

0.20

1.06 (0.94-1.18)

0.35

LSP1 3817198

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.12 (1.02-1.24)

 

1.19 (0.99-1.45)

 

1.08 (0.90-1.28)

 

1.08 (0.91-1.28)

 
 

aa

 

1.19 (1.00-1.40)

 

1.50 (1.11-2.02)

 

1.14 (0.84-1.55)

 

1.04 (0.79-1.38)

 
 

Per Allele

0,48

1.10 (1.02-1.18)

8.65E-03

1.21 (1.06-1.39)

4.41E-03

1.07 (0.94-1.22)

0.29

1.04 (0.92-1.18)

0.50

2q35

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.05 (0.93-1.19)

 

0.90 (0.72-1.14)

 

1.21 (0.98-1.50)

 

0.97 (0.79-1.19)

 
 

aa

 

1.20 (1.05-1.37)

 

1.09 (0.85-1.40)

 

1.28 (1.01-1.63)

 

1.21 (0.96-1.52)

 
 

Per Allele

0,38

1.10 (1.03-1.17)

7.47E-03

1.05 (0.93-1.19)

0.43

1.13 (1.00-1.27)

0.04

1.10 (0.98-1.23)

0.11

ESR1 7766585

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

1.23 (1.10-1.37)

 

1.12 (0.90-1.38)

 

1.26 (1.03-1.53)

 

1.25 (1.04-1.50)

 
 

aa

 

1.02 (0.74-1.41)

 

0.83 (0.43-1.58)

 

1.21 (0.69-2.13)

 

0.98 (0.57-1.66)

 
 

Per Allele

0,83

1.16 (1.05-1.27)

2.66E-03

1.05 (0.88-1.26)

0.60

1.20 (1.02-1.42)

0.03

1.16 (0.99-1.36)

0.06

HCN1 981782

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

0.97 (0.87-1.09)

 

0.92 (0.74-1.14)

 

1.03 (0.84-1.26)

 

1.00 (0.82-1.21)

 
 

aa

 

0.86 (0.75-0.99)

 

0.91 (0.70-1.18)

 

0.96 (0.75-1.22)

 

0.77 (0.61-0.98)

 
 

Per Allele

0,51

0.93 (0.87-1.00)

0.04

0.95 (0.83-1.08)

0.44

0.98 (0.87-1.11)

0.73

0.88 (0.78-0.99)

0.04

ESR1 851987

AA

 

1

 

1

 

1

 

1

 
 

Aa

 

0.91 (0.82-1.02)

 

0.96 (0.78-1.17)

 

0.92 (0.76-1.11)

 

0.87 (0.73-1.05)

 
 

aa

 

0.88 (0.74-1.05)

 

1.44 (1.06-1.95)

 

0.69 (0.50-0.96)

 

0.71 (0.52-0.98)

 
 

Per Allele

6.70E-03

0.93 (0.86-1.00)

0.06

1.12 (0.97-1.28)

0.12

0.86 (0.75-0.99)

0.04

0.86 (0.75-0.98)

0.02

  1. None of the SNPs showed any tendencies towards significant interactions after stratification according to BMI (Table 3).